| ROCplot. org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients JT Fekete, B Győrffy International journal of cancer 145 (11), 3140-3151, 2019 | 231 | 2019 |
| Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients JT Fekete, Á Ősz, I Pete, GR Nagy, I Vereczkey, B Győrffy Gynecologic oncology 156 (3), 654-661, 2020 | 57 | 2020 |
| Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030 O Menyhárt, JT Fekete, B Győrffy Clinical Epidemiology, 1093-1108, 2018 | 43 | 2018 |
| A transcriptomic immunologic signature predicts favorable outcome in neoadjuvant chemotherapy treated triple negative breast tumors J Pérez-Pena, J Tibor Fekete, R Páez, M Baliu-Piqué, JÁ García-Saenz, ... Frontiers in immunology 10, 2802, 2019 | 29 | 2019 |
| Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies O Menyhárt, JT Fekete, B Győrffy Carcinogenesis 42 (6), 804-813, 2021 | 22 | 2021 |
| Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors SA Kovács, JT Fekete, B Győrffy Acta Pharmacologica Sinica 44 (9), 1879-1889, 2023 | 21 | 2023 |
| Gene expression indicates altered immune modulation and signaling pathway activation in ovarian cancer patients resistant to topotecan O Menyhárt, JT Fekete, B Győrffy International Journal of Molecular Sciences 20 (11), 2750, 2019 | 20 | 2019 |
| A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines JT Fekete, B Győrffy Computational and Structural Biotechnology Journal 20, 2885-2894, 2022 | 12 | 2022 |
| Co-transmission of alpha-synuclein and TPPP/p25 inhibits their proteolytic degradation in human cell models A Lehotzky, J Oláh, JT Fekete, T Szénási, E Szabó, B Győrffy, G Várady, ... Frontiers in molecular biosciences 8, 666026, 2021 | 11 | 2021 |
| miRNA expression signatures of therapy response in squamous cell carcinomas JT Fekete, Á Welker, B Győrffy Cancers 13 (1), 63, 2020 | 8 | 2020 |
| Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers J Lazar, P Antal-Szalmas, I Kurucz, A Ferenczi, M Jozsi, I Tornyi, M Muller, ... Molecular & Cellular Proteomics 22 (7), 2023 | 4 | 2023 |
| New transcriptomic biomarkers of 5-fluorouracil resistance JT Fekete, B Győrffy International Journal of Molecular Sciences 24 (2), 1508, 2023 | 3 | 2023 |
| Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma K Mangó, F Fekete, ÁF Kiss, R Erdős, JT Fekete, T Bűdi, E Bruckner, ... Scientific Reports 13 (1), 11770, 2023 | 1 | 2023 |
| Resistance to Combined Anthracycline–Taxane Chemotherapy Is Associated with Altered Metabolism and Inflammation in Breast Carcinomas O Menyhárt, JT Fekete, B Győrffy International Journal of Molecular Sciences 25 (2), 1063, 2024 | | 2024 |
| Increased activity of inflammation-related signaling pathways in anthracycline-paclitaxel resistant breast carcinomas O Menyhárt, TJ Fekete, B Győrffy Magyar Onkologia 67 (3), 203-212, 2023 | | 2023 |
| Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination T Resál, P Bacsur, M Horváth, K Szántó, M Rutka, A Bálint, A Fábián, ... Therapeutic Advances in Gastroenterology 16, 17562848231183529, 2023 | | 2023 |
| Prediktív biomarkerek vizsgálata különböző daganattípusokban JT Fekete | | 2022 |
